Clinical trial · Observational
COPD Care Pathway Among Patients With Cancer
User-Centered Design of a COPD Care Pathway for Patients With Cancer
NCT05984680CI-TRIAL-00114911completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | — | UNRESOLVED | — |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational Phase 1 | Other | — | UNRESOLVED |
| Observational Phase 2, Group I | Other | — | UNRESOLVED |
| Observational Phase 2, Group II | Other | — | UNRESOLVED |
| Observational Phase 3 | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Observational Phase 1
- description
- Participants complete surveys
- interventionNames
- Other: Observational Phase 1
- label
- Observational Phase 2, Group I
- description
- Participants complete an interview and participate in a focus group on study.
- interventionNames
- Other: Observational Phase 2, Group I
- label
- Observational Phase 2, Group II
- description
- Participants complete an interview and participate in guided tours of the oncology clinic on study.
- interventionNames
- Other: Observational Phase 2, Group II
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:
* The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
1. patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
2. provider who currently works at least part-time in a medical oncology clinic or
3. provider who works at least part-time to care for patients with known or suspected COPD.
A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
* Ability to understand and agree to participate on the study as described by the study information sheet.
* Capability of speaking or reading English.
Exclusion Criteria: Severe psychiatric symptoms; unusual social situation; or critical instability that would limit adherence to the study requirements, as determined by the study team.References
Publications (1)
- DERIVEDLycan TW Jr, Price SN, Mileham K, Stoen E, Ruiz J, Ohar JA, Norton D, Koch AL, Petty WJ, Birken SA. User-centered design of a COPD care pathway for patients with cancer: a mixed-methods clinical trial protocol. Future Oncol. 2025 Oct;21(25):3259-3273. doi: 10.1080/14796694.2025.2562715. Epub 2025 Oct 14. PMID 41084760